Aytu BioPharma, Inc. (AYTU) vs Rockwell Medical, Inc. (RMTI)

Aytu BioPharma, Inc. and Rockwell Medical, Inc. are both Drug Manufacturers Specialty & Generic companies. Rockwell Medical, Inc. is the larger, with a market value of $32.2M against $21.8M — 1.5× the size. Aytu BioPharma, Inc. grew revenue faster over the last twelve months: −13.3% against −21.1%. Rockwell Medical, Inc. has the higher net margin (−7.33% vs −24.8%) and the higher return on invested capital (−14.6% vs −20.0%). Across the 18 metrics below, Rockwell Medical, Inc. leads on 11 and Aytu BioPharma, Inc. on 7.

Valuation

Metric AYTU RMTI Drug Manufacturers Specialty & Generic median
P/E n/m n/m 19.25
P/S 0.44 0.42 2.11
P/B 0.71 0.84 1.78
Price to free cash flow 7.77 n/m 16.14
EV/EBITDA n/m n/m 12.58
EV/Sales 0.28 0.20 2.73
Earnings yield (67.16%) (18.03%) (4.38%)
Free cash flow yield 12.87% (3.33%) 0.00%

Profitability

Metric AYTU RMTI Drug Manufacturers Specialty & Generic median
Gross margin 63.95% 17.71% 53.94%
Operating margin (14.44%) (6.52%) 0.00%
Net margin (24.76%) (7.33%) 0.00%
Free cash flow margin 5.62% 2.47% 0.00%
Return on equity (52.55%) (15.53%) (0.40%)
Return on assets (12.44%) (9.32%) (3.32%)
Return on invested capital (19.99%) (14.58%) 0.00%

Growth

Metric AYTU RMTI Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) (13.27%) (21.12%) 10.01%
EPS growth (last fiscal year) 46.30% (870.87%) 49.06%
Revenue growth, 5-year CAGR (2.59%) 2.17% 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AYTU RMTI Drug Manufacturers Specialty & Generic median
Debt to equity 0.48 0.26 0.05
Current ratio 1.13 3.25 2.31
Net debt to EBITDA 2.17 7.40 0.97

Dividend

Metric AYTU RMTI Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.57%
Payout ratio — — 0.27

Size

Metric AYTU RMTI Drug Manufacturers Specialty & Generic median
Market cap 21.84m 32.16m 276.90m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack